Reincarnating autoimmunity: Immune-related adverse events as new diseases

Co-Director, Comprehensive Melanoma and High-Risk Cancer Program, Director, Melanoma Medical Oncology, Taussig Cancer Institute, and Co-Founder and Co-Director of Management of Checkpoint Inhibitor Toxicity, Cleveland Clinic; Associate Staff, Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH; Clinical Assistant Professor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH; Panel Member, American Society of Clinical Oncology Guidelines on Immune-Related Adverse Events